Neutralization of the anthrax toxin by antibody-mediated stapling of its membrane penetrating loop
Abstract Anthrax infection is associated with severe illness and high mortality. Protective antigen (PA) is the central component of the anthrax toxin, which is the main virulent factor of anthrax. Upon endocytosis, PA opens a pore in the membranes of endosomes, through which the toxin’s cytotoxic enzymes are extruded. The PA pore is formed by a cooperative conformational change where PA’s membrane-penetrating loops associate, forming a hydrophobic rim that pierces the membrane. Due to its crucial role in anthrax progression, PA is an important target of monoclonal antibodies-based therapy. cAb29 is a highly effective neutralizing antibody against PA. We determined the cryo-EM structure of PA in complex with the Fab portion of cAb29. We found that cAb29 neutralizes the toxin by clamping the membrane-penetrating loop of PA to a static region on PA’s surface, thereby preventing pore formation. Therefore, our results provide the structural basis for the antibody-based neutralization of PA and bring to focus the membrane-penetrating loop of PA as a target for the development of better anti-anthrax vaccines..
Medienart: |
Preprint |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
bioRxiv.org - (2022) vom: 24. Dez. Zur Gesamtaufnahme - year:2022 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Hoelzgen, Fabian [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
doi: |
10.1101/2021.04.18.440036 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
XBI020376413 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | XBI020376413 | ||
003 | DE-627 | ||
005 | 20230429091225.0 | ||
007 | cr uuu---uuuuu | ||
008 | 210419s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1101/2021.04.18.440036 |2 doi | |
035 | |a (DE-627)XBI020376413 | ||
035 | |a (biorXiv)10.1101/2021.04.18.440036 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Hoelzgen, Fabian |e verfasserin |4 aut | |
245 | 1 | 0 | |a Neutralization of the anthrax toxin by antibody-mediated stapling of its membrane penetrating loop |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Abstract Anthrax infection is associated with severe illness and high mortality. Protective antigen (PA) is the central component of the anthrax toxin, which is the main virulent factor of anthrax. Upon endocytosis, PA opens a pore in the membranes of endosomes, through which the toxin’s cytotoxic enzymes are extruded. The PA pore is formed by a cooperative conformational change where PA’s membrane-penetrating loops associate, forming a hydrophobic rim that pierces the membrane. Due to its crucial role in anthrax progression, PA is an important target of monoclonal antibodies-based therapy. cAb29 is a highly effective neutralizing antibody against PA. We determined the cryo-EM structure of PA in complex with the Fab portion of cAb29. We found that cAb29 neutralizes the toxin by clamping the membrane-penetrating loop of PA to a static region on PA’s surface, thereby preventing pore formation. Therefore, our results provide the structural basis for the antibody-based neutralization of PA and bring to focus the membrane-penetrating loop of PA as a target for the development of better anti-anthrax vaccines. | ||
650 | 4 | |a Biology |7 (dpeaa)DE-84 | |
650 | 4 | |a 570 |7 (dpeaa)DE-84 | |
700 | 1 | |a Zalk, Ran |e verfasserin |4 aut | |
700 | 1 | |a Alcalay, Ron |e verfasserin |4 aut | |
700 | 1 | |a Schwartz, Sagit Cohen |e verfasserin |4 aut | |
700 | 1 | |a Garau, Gianpiero |e verfasserin |4 aut | |
700 | 1 | |a Shahar, Anat |e verfasserin |4 aut | |
700 | 1 | |a Mazor, Ohad |e verfasserin |4 aut | |
700 | 1 | |a Frank, Gabriel A. |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2022) vom: 24. Dez. |
773 | 1 | 8 | |g year:2022 |g day:24 |g month:12 |
856 | 4 | 0 | |u https://doi.org/10.1107/s2059798321007816 |z lizenzpflichtig |3 Volltext |
856 | 4 | 0 | |u http://dx.doi.org/10.1101/2021.04.18.440036 |z kostenfrei |3 Volltext |
912 | |a GBV_XBI | ||
912 | |a SSG-OLC-PHA | ||
951 | |a AR | ||
952 | |j 2022 |b 24 |c 12 |